SCHEMBL3171564

SCHEMBL3171564

COc1ccc(N2CCN(C(=O)C(=O)Nc3cc(NCCNC(C)=O)nc(-c4ccccc4)n3)CC2C)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 1/20 0.45
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CLK4 Q9HAZ1 1/20 0.41
▸ MTNR1A P48039 2/20 0.41
▸ MTNR1B P49286 2/20 0.41
▸ ADORA3 P0DMS8 9/20 0.40
▸ SLC1A2 P43004 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ ADORA2A P29274 2/20 0.38
▸ ADORA1 P30542 2/20 0.38
▸ ADORA2B P29275 2/20 0.37
▸ CHRM2 P08172 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ GFER P55789 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3260451 0.87 SLC1A2 (0.52) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3165370 0.87 GFER (0.47) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3169880 0.86 ADORA3 (0.46) CHRM4CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL3156095 0.83 SLC1A2 (0.46) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3175769 0.80 ADORA2A (0.45) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3177170 0.80 NTSR1 (0.46) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3171368 0.80 ADORA3 (0.45) TSHRADORA3SLC1A2ADORA2AADORA1
SCHEMBL3166495 0.80 SLC1A2 (0.44) CYP1A2CYP3A4CYP2D6TSHRCYP2C19
SCHEMBL3246822 0.79 ADORA2B (0.60) CHRM4CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL3155892 0.79 ADORA2A (0.46) CYP1A2CYP3A4CYP2D6TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback